Author:
Puerta E.,Oberto J.,Guerra M.,Reyna E.,Mejia J.,Reyna N.,Torres D.,Santos J.
Subject
Obstetrics and Gynecology,Reproductive Medicine
Reference35 articles.
1. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women;Leonetti;Menopause,2003
2. A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone;Shulman;J Womens Health (Larchmt),2006
3. Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea;Battino;Gynecol Obstet Invest,1996
4. Low dose continuous combined hormone replacement therapy: Early and late postmenopausal effect on endometrium;Chantler;J Ultrasound Med,2000
5. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels;Spencer;Br J Obstet Gynaecol,1999